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Abstract 
We present evidence for the presence of the folate metabolism enzyme methenyltetrahydrofolate synthetase (MTHFS) in mitochondria. 
MTHFS activity was identified in the matrix of mitochondria purified from human liver biopsies. Mitochondrial nd cytoplasmic MTHFS 
specific activities are similar, 85% of the total cellular MTHFS activity is in the cytoplasm and both native enzymes have similar 
molecular weights (approximately 25 kDa). Studies using purified mitochondrial MTHFS from CA46 human Burkitt lymphoma cells 
reveal that mitochondrial MTHFS behaves kinetically like the cytoplasmic enzyme with K m values of 4.7, 0.8 and 22 /xM respectively 
for (6R,S)-5-formyltetrahydrofolate monoglutamate, (6S)-5-formyltetrahydrofolate pentaglutamate and ATP. This finding adds to 
previous observations that various folate-dependent zymes reside in the mitochondria of eucaryotic cells. Intracellular tetrahydrofolate 
metabolism is highly compartmentalized an  mitochondrial MTHFS activity is necessary for the entry of mitochondrial 5-formyltetra- 
hydrofolate into the mitochondrial folate pool. 
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1. Introduction 
Methenyltetrahydrofolate synthetase (MTHFS; EC 
6.3.3.2) catalyses the unidirectional ATP- and MgZ+-de- 
pendent ransformation of 5-formyltetrahydrofolate (N 5- 
CHO-Ha-PteGlu) to 5,10-methenyltetrahydrofolate (N 5-1°- 
CH+-Hn-PteGIu). Mammalian MTHFS activity has been 
purified from sheep [1], rabbit [2] and human liver [3] and 
the bacterial enzyme from Lactobacillus casei [4]. The 
enzyme's ubstrate, 5-formyltetrahydrofolate arises from 
the enzymatic atalysis of 5,10-methenyltetrahydrofolate 
by serine hydroxymethyltransferase [5]. The produced 5- 
formyltetrahydrofolate polyglutamates are tight-binding in- 
hibitors of serine hydroxymethyltransferase, suggesting that 
their production could be involved in regulating the en- 
zyme's activity and thus the flow of one-carbon residues 
necessary for de novo purine and pyrimidine syntheses 
[6,7]. MTHFS could thus play a role in a putative regula- 
tory loop with serine hydroxymethyltransferase by modu- 
lating intracellular 5-formyltetrahydrofolate polyglutamate 
levels [7]. We have also previously shown that the inhibi- 
tion of MTHFS in vivo results in increased intracellular 
5-formyltetrahydrofolate polyglutamate l vels which in- 
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hibit phosphoribosyl 5-aminoimidazole 4-carboxamide ri-
bonucleotide formyltransferase, de novo purine synthesis 
and cell growth [8]. The inhibitory potential of 5-for- 
myltetrahydrofolate polyglutamates against a number of 
other folate-dependent enzymes [7] also underlies the po- 
tential importance of MTHFS as a detoxifying enzyme. 
MTHFS activity is also a potentially important enzyme 
in cancer chemotherapy since it is the first enzymatic step 
involved in the intracellular transformation of the 5-for- 
myltetrahydrofolate (leucovorin TM) administered to cancer 
patients either as a rescue agent in high dose methotrexate 
regimens [9] or more recently to enhance 5-fluorouracil's 
cytotoxic efficacy in the chemotherapy of colorectal cancer 
[lO]. 
Mammalian cell mitochondria contain pteroylpolygluta- 
mates and a number of folate-dependent enzymes, and 
tetrahydrofolate metabolism is highly compartmentalized 
between the cytosol and mitochondria [11]. 5-formyltetm- 
hydrofolate accounts for 11.5% of total folates in rat liver 
mitochondria [12] where it is also produced enzymatically 
through serine hydroxymethyltransferase since Chinese 
hamster ovary cell mutants lacking this mitochondrial c- 
tivity [13] contain no mitochondrial 5-formyltetrahydrofo- 
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late (Shane, B., personal communication). A mitochondrial 
MTHFS activity would thus be required for the entry of 
mitochondrial 5-formyltetrahydrofolate into the mitochon- 
drial folate pool and to prevent he possibly deleterious 
effects of its intramitochondrial accumulation. 
In this paper, we present evidence supporting the pres- 
ence of MTHFS activity in the matrix of human liver 
mitochondria nd describe the characteristics of purified 
mitochondrial enzyme from human CA46 Burkitt lym- 
phoma cells. 
2. Experimental procedures 
2.1. Chemicals 
(6R,S)-NS-CHO-H4-PteGIu (calcium salt) and PteGlu s
were purchased from B. Schircks Laboratories (Jona, 
Switzerland). The stereospecific reduced folate (6S)-N 5- 
CHO-Ha-PteGlu 5 was prepared from PteGlu 5 as previ- 
ously described [8]. (6R,S)-NS-CHO-Hn-PteGlu (potas- 
sium salt) was made from the calcium salt by exposure to 
potassium oxalate and the calcium oxalate formed was 
removed by centfifugation [3]. Aminohexyl-Sepharose-4B, 
Blue Sepharose CL-6B, Sephadex G-25 and Sephacryl 
S-200 HR were obtained from Pharmacia LKB Biotech- 
nology (Piscataway, NJ). (6R, S)-NS-CHO-H4-PteGIu - 
aminohexyl-Sepharose-4B was prepared as previously de- 
scribed [3]. [2-14 C]Tryptamine bisuccinate (50mCi/mmol) 
was purchased from NEN-Dupont (Boston, MA). All other 
chemicals were of reagent grade and purchased either from 
Sigma, Fisher Scientific (Fairlawn, NJ) or Boehringer 
Mannheim (Penzberg, Germany). 
2.2. Cell culture 
Human Burkitt lymphoma CA46 cells (American Type 
Culture Collection, Rockville, MD) were grown in suspen- 
sion culture at 37 ° C in the presence of 5% CO 2 in RPMI 
1640 medium supplemented with 10% heat-inactivated 
fetal bovine serum, 2 mM L-glutamine, penicillin (100 
units/ml) and streptomycin (100 ~g/ml)  (Gibco, Grand 
Island, NY). 
Potter-Elvehjem homogenizer in 5 volumes of ice-cold 
deionised water while the human liver biopsies were ho- 
mogenized in 5 volumes of ice-cold 0.25 M sucrose, 8.6 
mM NaC1, 15 mM Tris-HC1 and 5 mM EDTA (pH 7.5). 
The homogenate was centrifuged at 5000 × g for 10 min 
and the supernatant centrifuged again at 12 000 X g for 20 
min. The supernatant solution (cytosolic fraction) was 
removed from the sediment (mitochondria containing frac- 
tion) and kept at - 80 ° C in the presence of 0.1% Tween-20 
for further analysis. The mitochondria containing fraction 
was resuspended in 1 volume of the homogenization buffer 
and applied to a sucrose gradient consisting of two layers 
of solutions containing (from top to bottom) 2 ml of 1.0 M 
sucrose, 10 mM Tris, 5 mM EDTA (pH 7.5) and 2 ml of 
1.5 M sucrose, 10 mM Tris, 5 mM EDTA (pH 7.5). 
Following centrifugation (24 000 X g for 30 min) the puri- 
fied mitochondria were collected at the interface of the 1.0 
M and 1.5 M sucrose solutions. Tween-20 (0.1%) was 
immediately added to the purified mitochondria nd the 
suspension was frozen at -80  ° C. Upon thawing, the 
suspension was sonicated (5 s, four times) prior to further 
analysis. 
A portion of the purified human liver mitochondria 
from the second patient was further subfractionated by low 
concentration digitonin treatment as previously described 
to further localize MTHFS activity within the mito- 
chondria [15]. Briefly, freshly prepared mitochondria were 
pelleted by centrifugation a d resuspended in 0.3 ml of the 
homogenization buffer. An equal volume of digitonin solu- 
tion (1.2%) was added and the solution gently stirred in a 
ice bath for 15 min. The lysate was then centrifuged at 
10000 X g for 10 min. The supernatant consists of outer 
mitochondrial membranes and intermembrane components 
while the mitoplasts are pelleted. The pellet was washed 
twice and then resuspended in 0.1 ml of the homogeniza- 
tion buffer prior to sonication. The extract was centrifuged 
again to obtain the mitochondrial matrix components in the 
supernatant. Tween-20 was then added to stabilize MTHFS 
activity. 
2.4. Mitochondrial methenyltetrahydrofolate synthetase 
purification 
2.3. Subcellular f actionation 
Human liver was obtained in the operating room from 
two patients undergoing open liver biopsies. Macroscopi- 
cally normal liver was immediately dissected from any 
abnormal tissue and immersed in an ice-cold solution 
prepared from 0.25 M sucrose, 8.6 mM NaC1, 15 mM 
Tris-HC1 and 5 mM EDTA (pH 7.5). Subcellular f actiona- 
tion was initiated within the hour. For CA46 cells, approx- 
imately 1 X 10 H cells were first swelled in ice-cold 
deionised water for 30 min prior to homogenization. Mito- 
chondria were isolated according to previously described 
protocols [14]. The swelled cells were homogenized with a 
Human mitochondrial MTHFS was purified from mito- 
chondria isolated from CA46 cells. Prior to chromatog- 
raphy, the mitochondrial extracts were first centrifuged 
(5000×g, 10 min) through a 3 X8 cm column of 
Sephadex G-25. The fraction was then purified by Blue 
Sepharose and (6R,S)-NS-CHO-H4-PteGlu-aminohexyl - 
Sepharose chromatography as previously described [8]. 
Active fractions were pooled prior to kinetic studies. 
2.5. Enzyme assays 
MTHFS activity was measured by monitoring the in- 
crease in absorbance at 360 nm due to the formation of 
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Table 1 
Subcellular distribution of methenyltetrahydrofolate syn hetase in human liver 
247 
Patient Fraction MTHFS LDH CcO Fum MAO 
units/mg (× 10 -4 ) ~mol/min/mg /xmol/min/mg (× 10 -2) 
1 Cyto 4.9 (85) 1.27 (99) 0.49 (34) 
Mito 11.0 (15) 0.06 (1) 8.55 (66) 
2 Cyto 3.6 (85) 0.77 ( > 99) 1.47 (42) 
Mito 3.0 (15) 0.01 (< 1) 11.5 (58) 
Matrix (66) 
Outer membrane (34) 
(72) (12) 
(28) (88) 
Subcellular f actionations were performed on fresh liver biopsy samples from two patients. MTHFS, lactate dehydrogenase (LDH) and cytochrome-c 
oxydase (CcO) activities were measured in cytoplasmic (Cyto) and mitochondrial (Mito) fractions. In patient no. 2, purified mitochondria were also treated 
with low concentration digitonin to remove their outer membranes and MTHFS, fumarase (Fum) and monoamine oxydase (MAO) activities measured in
the outer membrane and matrix fractions. Results represent the means of duplicate assays and values in parentheses are the percentage of total enzyme 
activity in each fraction. 
NsU°-CH+-H4-PteGlu (F360:25 .1  X 10 3 M - l  ×cm- l ) .  
One unit of activity represent 1 /zmol of NsI°-CH+-H4 - 
PteGlu formed per min. Reactions were carried out in a 
quartz cuvette of 1 cm optical path length and the tempera- 
ture maintained at 30 ° C using a water-jacketed sample 
compartment. The reaction mixture contains 50 mM MES 
(pH 6.0), 10 mM fl-mercaptoethanol, 10 mM magnesium 
acetate, 0.5 mM ATP a~ld 0.2 mM (6R,S)-NS-CHO-H4 - 
PteGlu [3]. 
Lactate dehydrogenase activity, a cytosolic marker, was 
measured by monitoring 'Ehe decrease in absorbance at 340 
nm due to the oxidation of NADH (E340:6.22 × 10 3 
M-  1 X cm-  ~). Enzyme activity was expressed in /xmol of 
NADH oxidized per min. Reactions were carried out as 
previously described in a reaction mixture containing 10 
mM Tris-HC1 (pH 7.3), I).2 mM NADH, 1.0 mM sodium 
pyruvate and 0.01% Triton X-100 [16]. 
Cytochrome-c oxidase activity, a mitochondrial marker, 
was measured by monitoring the decrease in absorbance at 
550 nm due to the oxidation of cytochrome-c (E550:15.3 
× 103 M- l× cm-~). Enzyme activity was expressed as 
/zmol of cytochrome-c oxidized per min. Reactions were 
carried out as previously described in a reaction mixture 
containing 6.2 mM K2HPO 4 and 33.8 mM KH2PO 4 (pH 
6.2), 0.2% Lubrol PX and 0.25 mg cytochrome-c [17]. 
Fumarase activity, a mitochondrial matrix marker, was 
measured by monitoring the increase in absorbance at 240 
nm due to the formation of fumarate  (E240:2.44 X l03 
M -~ ×cm-~) .  One unit of activity represent 1 /xmol of 
fumarate formed per min. Reactions were carried out in a 
reaction mixture containing 50 mM malate in 0.1 M 
phosphate buffer (pH 7.6) [18]. 
Monoamine oxidase activity, an outer mitochondrial 
membrane marker, was measured by detecting the forma- 
tion of [2-14C]indoleacetic a id from [2-14C]tryptamine. In 
a typical assay, 10/xl  of subfractioned sample were mixed 
with 250 /zl of [14C]tryptamine] in phosphate buffer (pH 
7.4) and incubated at 37°C for 20 min. Reactions were 
stopped by the addition of 0.2 ml 2 N HC1 and the 
deaminated radioactive products were extracted into 6 ml 
toluene by shaking. After centrifugation, 4 ml aliquots of 
the organic material were counted in a scintillation counter. 
Blank values were determined by incubating [lac]trypta- 
mine with boiled samples [19]. 
Protein concentrations were determined using the Lowry 
assay with bovine serum albumin as the standard. 
2.6. Gel  f i l t rat ion 
Molecular weights of mitochondrial and cytosolic en- 
zyme were determined by gel filtration using a Sephacryl 
S-200 HR column (1.0 × 30 cm) on a FPLC system 
(Pharrnacia-LKB Biotechnology). Calibration standards 
and samples were run in 20 mM Pipes, 0.5 M potassium 
chloride, 20 mM mercaptoethanol and 0.1% (v /v )  Tween 
20 at pH 7.0 (flow rate: 0.25 ml /min) .  MTHFS was 
Table 2 
Purification of human mitochondrial methenyltetrahydrofolate syn hetase 
Total Volume Total protein Activity Specific activity Purification Yield 
(ml) (mg) (units) (units/mg) (-fold) (%) 
Cytoplasm 10t3 800 0.903 (79) 1.12 X 10 -3 
Mitochondria 10 180 0.236 (21) 1.31 X 10 -3 1 100 
Blue Sepharose 40 0.021 0.040 1.90 1,450 17 
Folinate Sepharose 10 < 0.001 0.013 > 13 > 10,000 6 
Human Burkitt lymphoma CA46 cells were cultured and subcellular fractions prepared. Lactate dehydrogenase nd cytochrome-c oxydase activities were 
respectively distributed with 1.Z3 and 97% of their total activities in the mitochondrial fraction. Mitochondrial MTHFS was purified by sequential b ue 
sepharose and folinate sepharose chromatographies. MTHFS activity and protein concentrations were determined in all fractions. Values in parentheses are 
the percentage of total MTHFS activity in each fraction. 
248 R. Bertrand et al. / Biochimica et Biophysica Acta 1266 (1995) 245-249 
1.o 
E 0.8 
¢ 
o o0 
N 0.6 
m 0.4  
< 0.2 
0.0, 
0.4 
>-  
N 0.3 
< 
F- 0.2 
=E 
~ o.1 
0.0 
0 
67 
I 
o 
Z5 
or 
I 
3.7 
O j!/ 
o 
d._~!  * I , , -¢-~. . . . .  %" 
4 8 12 16 20 
FRACTION (ml )  
Fig. 1. FPLC elution profiles of mitochondrial and cytosolic MTHFS 
activity on Sephacryl 200-HR 10/30. Upper panel: the elution profiles of 
the molecular weight standards were monitored by UV absorbance at280 
nm. The numbers above each peak represent the molecular weight of each 
standard in kDa. V o represents he void volume. Lower panel: Mitochon- 
drial (closed triangles) and cytoplasmic (open triangles) subcellular f ac- 
tions were applied to a Sephacryl 200-HR 10/30 column on a FPLC 
system. MTHFS activity was detected by enzymatic activity in each 
250-/~1 collected fraction. The sample volume was 200 /xl and the elution 
buffer 20 mM Pipes, 0.5 M KCI, 20 mM mercaptoethanol, 0.1% (v/v) 
Tween 20 (pH 7.0). The flow rate was 250 /xl/min. 
detected in the effluent by testing for enzyme activity. The 
calibration standards used were bovine serum albumin (67 
kDa), ovalbumin (43 kDa), chymotrypsinogen A (25 kDa) 
and ribonuclease A (13.7 kDa). Column void volume was 
determined using blue dextran 2000. 
3. Results and discussion 
3.1. Subcellular localization of MTHFS 
Human liver mitochondria were found to contain simi- 
lar specific activity of MTHFS than cytosolic extracts with 
85% of the total cellular activity in the cytoplasm (Table 
1). Mitochondria preparations were free of cytoplasmic 
contaminants as determined by lactate dehydrogenase ac- 
tivity ( < 1%). Cytochrome-c oxidase contamination f the 
cytosolic fraction likely resulted from some mitochondrial 
breakage during homogenization. Mitochondrial MTHFS 
activity was further localized in the second human liver 
biopsy sample by subfractionating mitochondrial outer- 
membrane and intermembrane components from inner 
membrane and matrix components with low concentration 
digitonin treatment. Most of the mitochondrial MTHFS 
activity was found in the matrix components. Its distribu- 
tion between the matrix and the outer membrane fraction 
was similar to that of fumarase activity, the matrix marker, 
and reflected some disruption of the mitochondrial inner 
membranes during digitonin treatment. The matrix prepara- 
tion was relatively free of outer membrane as determined 
by monoamine oxidase activity. These results indicate that 
the mitochondrial MTHFS activity resides in the mitochon- 
drial matrix. 
Similar sublocalization of folate-dependent enzymes 
have been reported for serine hydroxymethyltransferase, 
10-formyltetrahydrofolate synthetase, 5,10-methenyltetra- 
hydrofolate cyclohydrolase, 5,10-methylenetetrahydrofo- 
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Fig. 2. Substrate affinity for purified mitochondrial MTHFS. Double 
reciprocal plots (1/[S] versus I /V )  with (6RS)-NS-CHO-H4-PteGIul 
(panel A), (6S)-NS-CHO-H4-PteGIu5 (panel B) and ATP (panel C) as 
substrates. Initial velocities are expressed in [/xmol/min/ml × 10 -5 ]-J 
(y axis) versus ubstrate concentration i  [/xM]-i (x axis) and represent 
the mean of two determinations. Velocities were measured in the pres- 
ence of 15/xM (open triangles), 25/xM (closed circles) and 50/~M ATP 
(open circles) in panel A; 25/zM (closed circles) and 50/~M ATP (open 
circles) in panel B, and with 2.5 /zM (open diamonds), 5 /zM (closed 
squares) and 10/zM (6RS)-NS-CHO-Ha-PteGlu] (open squares) in panel 
C. 
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late dehydrogenase and folylpolyglutamate synthetase [20-  
23]. However, we could not detect mitochondrial MTHFS 
activity in rabbit liver (data not shown). This interspecies 
difference in 5-formyltetrahydrofolate metabolism is also 
indicated by the observation that cytosolic rabbit liver 
MTHFS specific activity is approximately 4000-fold higher 
[2] than in our human liw'.r biopsy samples. 
3.2. Molecular weight of  mitochondrial MTHFS 
The molecular weight of native human liver mitochon- 
drial enzyme was determined by gel filtration chromatog- 
raphy on Sephacryl-200 HR to be approximately 25 kDa 
and to be almost identical to the cytosolic liver enzyme 
(Fig. 1). These molecular weights are similar to the ones 
previously reported for human and rabbit liver MTHFS 
[2,3]. 
3.3. Purification and kinetic studies of  mitochondrial 
MTHFS 
MTHFS was purified > 10,000-fold from CA46 cell 
mitochondria. The purification protocol is shown in Table 
2. We were unable to determine the protein concentration 
after the last purification step due to the small amount of 
protein left and the estimated specific activity following 
purification was > 13 units /mg.  The K m values of 
(6R,S)-NS-CHO-H4PteGlu, (6S)-NS-CHO-HaPteGlu5 and 
ATP were found to be ,4.7 /zM, 0.8 /xM and 22 /xM 
respectively (Fig. 2). These values are very similar to the 
ones reported previously for purified human liver MTHFS 
(4.4/xM, 0.6 /zM and 20 ~M)  [3]. The increased affinity 
for the pentaglutamate substrate is consistent with the 
observation that most pteroylpolyglutamate derivatives bind 
to folate-dependent enzymes with increased affinity com- 
pared to the monoglutamate d rivatives [24]. Initial-veloc- 
ity plots (Fig. 2a,c) intersected, indicating that the mito- 
chondrial enzyme catalyzes a sequential as opposed to a 
ping-pong mechanism. A similar mechanism has also been 
reported for rabbit and human liver cytosolic MTHFS 
[2,3]. 
3.4. Significance 
Mitochondrial MTHFS activity shows similar character- 
istics in terms of molecular weight, substrate affinity and 
enzyme mechanism compared to the cytoplasmic activity. 
We have recently reported the presence of several human 
cDNA isoforms coding for MTHFS [25] and are investigat- 
ing to determine if one of these isoforms encodes for a 
mitochondrial signal sequence. The presence of MTHFS 
activity in the mitochondrial matrix correlates with previ- 
ous observations that tetrahydrofolate metabolism is highly 
compartmentalized between the cytosol and mitochondria 
in eucaryotic ells. 
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